IFNG and neoplasm: Therefore, HLA-I downregulation produced by reversible molecular alterations can be corrected in vitro by IFN-γ and other cytokines [32,33] or recovered by immunotherapy that can stimulate a release of T-helper type I (TH1) cytokines in the tumor microenvironment [34].